A Practical Guide to Express Pharma Magazine Advertising: Ad Rates, Formats, and Booking in India for 2025

Most pharma brand managers we speak to have heard of Express Pharma, but a surprising number have never seriously considered it as part of their media mix — which is a missed opportunity that we find genuinely puzzling, given that this publication lands directly on the desks of the people who actually make procurement, licensing, and formulary decisions in Indian pharma. The publication reaches somewhere in the neighbourhood of 55,000 to 60,000 qualified pharmaceutical industry professionals across India, which means your ad isn't competing with cat videos and food delivery notifications for attention; it's sitting inside a trade journal that your target audience has specifically chosen to read. That changes the nature of the engagement entirely.

What Is Express Pharma Magazine and Who Reads It?

Express Pharma, published by Indian Express Limited — part of the well-regarded Indian Express Group — has been the dominant trade publication for India's pharmaceutical and biotechnology sector for well over two decades. Originally launched as Express Pharma Pulse, the magazine rebranded and expanded its editorial scope to cover the full spectrum of the Indian pharma ecosystem: drug development, regulatory affairs, manufacturing, packaging technology, market research pharma trends, supply chain, and the business of healthcare more broadly. It is published fortnightly, which means advertisers get 24 issues per year to work with — a frequency that makes sustained campaign planning genuinely practical.

What sets Express Pharma apart from general healthcare publications is the specificity of its editorial mandate; it isn't written for doctors or patients, it is written for pharmaceutical industry professionals — the CEOs, CMDs, heads of marketing, regulatory affairs managers, production heads, and procurement officers who collectively drive the decisions that matter to B2B pharma advertising. The editorial team, based primarily out of Mumbai, has built a reputation for rigorous coverage of pharmaceutical market news, policy changes, and industry analysis that practitioners actually find useful, which is why the readership tends to be genuinely engaged rather than passive. At SmartAds, we always tell our clients that the quality of attention a medium commands is at least as important as the quantity of eyeballs it delivers — and on that metric, Express Pharma scores unusually well.

The publication is also closely associated with several quarterly specials that carry their own distinct advertising opportunities: Pharma Technology Review, which focuses on manufacturing and process technology; LABNEXT, which covers laboratory equipment and diagnostics; and the Packaging Special, which addresses pharmaceutical packaging innovation. These special editions attract a somewhat different subset of the readership — more technically oriented, more procurement-focused — and they are worth considering separately when you are planning a product launch advertising campaign for equipment, reagents, or packaging solutions.

Why Should Pharma Brands Advertise in Express Pharma?

Frankly speaking, the case for pharma magazine advertising in a dedicated trade publication like Express Pharma rests on something that most digital-first media plans tend to undervalue: context. When a pharmaceutical industry professional reads Express Pharma, they are in a professional mindset — they are looking for information that helps them do their job better, which means your advertisement for a new API, a contract manufacturing service, a regulatory consultancy, or a pharma equipment brand is encountered in exactly the right frame of mind. This is the fundamental logic of B2B pharma advertising, and it is one that we have seen validated repeatedly in campaign after campaign.

The ROI argument for Express Pharma magazine advertising also holds up well when you run the numbers honestly. A full page advertisement in Express Pharma reaches somewhere in the range of 55,000 to 60,000 verified pharmaceutical industry professionals; when you divide that against the cost of the insertion, the effective CPM works out to roughly ₹800 to ₹1,200 per thousand impressions — which sounds high compared to programmatic digital, but the comparison is misleading because programmatic digital is not reaching pharma decision makers in a professional reading context. One automotive brand we worked with made a similar contextual shift when moving from mass media to trade publications, and the quality of inbound leads improved by a factor that genuinely surprised their sales team. The principle holds equally well in pharma.

On top of that, there is the brand visibility and brand recall dimension that tends to get underestimated in purely quantitative media evaluations. Express Pharma is a publication that pharmaceutical industry professionals keep — issues are passed around offices, referenced for the editorial content, and retained for the quarterly specials. An ad placed in the Pharma Technology Review quarterly, for instance, may be seen multiple times by the same reader over several weeks, which is a frequency pattern that digital display simply cannot replicate without becoming intrusive. The return on investment from print media advertising in India, particularly in well-targeted trade publications, is often better than the headline CPM figures suggest.

What Advertising Formats Are Available in Express Pharma?

Express Pharma offers a fairly standard but well-structured menu of print advertising formats, and understanding which format suits which objective is something we spend a fair amount of time discussing with new clients. The full page advertisement is the most commonly booked format — it gives you the full canvas of a right-hand page or a specified position, which is important for product launch advertising where you need to communicate a complex value proposition alongside strong visual branding. A double spread ad, which spans two facing pages, is the premium choice for corporate branding campaigns or major product launches where visual impact is the primary objective; we have seen these used very effectively by multinational pharma companies announcing new manufacturing facilities or product approvals.

The half page advertisement is the workhorse format for brands that need consistent presence across multiple issues but are working within a defined budget — it delivers meaningful brand visibility without the full-page investment, and when booked across six or more issues, it can build the kind of sustained recall that a single full-page insertion simply cannot achieve. There are also quarter-page options for smaller announcements and directory listings, though these tend to be used more for event promotions and classified-style communications than for brand-building. The inside front cover and back cover ad positions are the premium placements, commanding a significant rate premium over run-of-publication positions; the back cover ad, in particular, is consistently the most sought-after position in any print publication because it is the one position that is seen every time the magazine is picked up, regardless of whether the reader opens it.

Beyond the standard print formats, Express Pharma also accommodates advertorials — branded editorial content that is written in the style of the publication's own journalism but clearly identified as sponsored content. Advertorials tend to work particularly well for companies launching new technologies, new therapeutic areas, or new regulatory frameworks, where the story is genuinely complex and a traditional display ad cannot carry the full argument. At SmartAds, we have found that a well-crafted advertorial placed in Express Pharma, combined with a display ad in the same issue, produces a measurably stronger brand recall outcome than either format used in isolation.

How Much Does It Cost to Advertise in Express Pharma Magazine?

This is the question that almost every client asks first, and it is also the question that most online resources answer vaguely or not at all — which is frustrating if you are trying to make a genuine budget allocation decision. Based on our current rate intelligence and booking experience, a full page colour advertisement in Express Pharma works out to somewhere in the ballpark of ₹80,000 to ₹1,10,000 per insertion for run-of-publication placement, depending on the position and the issue. The inside front cover commands a premium that typically pushes the Express Pharma advertising cost to somewhere around ₹1,40,000 to ₹1,60,000, while the back cover ad — the most premium position in the book — is priced in the range of ₹1,60,000 to ₹1,90,000 per insertion.

A half page advertisement runs somewhere between ₹45,000 and ₹65,000 per insertion, which is a number that surprises many first-time advertisers when they compare it to what they are spending on LinkedIn sponsored content targeting the same professional audience — because on a verified CPM basis, Express Pharma ad rates are often more competitive than they initially appear. A double spread ad, which is essentially two full pages facing each other, is priced in the range of ₹1,60,000 to ₹2,20,000 depending on the position in the book; this is a significant investment, but for a national campaign announcing a major product launch or a corporate milestone, the impact is difficult to replicate with any other single placement. It is worth noting that all these figures are subject to GST on magazine ads at the applicable rate, which is currently 5% for print publications — a detail that sometimes catches finance teams off guard when the invoice arrives.

The quarterly specials — Pharma Technology Review, LABNEXT, and the Packaging Special — carry their own separate rate cards, and in our experience these are often slightly higher than the base fortnightly rate because the circulation for these issues tends to be enhanced and the shelf life is considerably longer. What a lot of people miss is that these special editions are often the single best value in the entire Express Pharma advertising portfolio for equipment manufacturers, lab suppliers, and packaging companies, because the readership for those specific issues is almost entirely composed of the procurement and technical decision-makers those brands most need to reach. We always recommend that clients in those categories prioritise at least one special edition insertion as part of their annual pharma magazine advertising plan.

What Is the Circulation and Readership of Express Pharma?

The Express Pharma magazine circulation figures that matter most for media planning are the ABC-certified numbers, because the Audit Bureau of Circulations provides independently verified data rather than publisher-claimed figures — and in our experience, the gap between claimed and audited circulation in trade publications can be surprisingly wide. Express Pharma's audited circulation has historically been in the range of 25,000 to 30,000 copies per issue, which is the paid and controlled circulation figure that ABC certifies; the readership, which accounts for pass-along readership within offices and institutions, is typically estimated at a multiplier of two to two-and-a-half times the circulation figure, which brings the effective readership to somewhere between 55,000 and 75,000 pharmaceutical industry professionals per issue.

The geographic distribution of that readership is heavily concentrated in the major pharma manufacturing and commercial hubs — Mumbai, which is both the headquarters of Express Pharma and the commercial capital of the Indian pharma industry; Delhi and the NCR region, which houses the regulatory and policy establishment; Hyderabad and Ahmedabad, which are major API and formulation manufacturing centres; and Bengaluru, which has become increasingly important as a biotech and pharmaceutical R&D hub. There is meaningful pan-India reach as well, including Tier 2 and Tier 3 cities where regional pharma companies and distributors are based, though the concentration in the major metros is pronounced. For a brand running a national campaign targeting pharmaceutical industry professionals across India, this geographic spread is actually quite well-matched to where the decision-making power in Indian pharma is concentrated.

The audience profile is what makes Express Pharma particularly valuable for B2B pharma advertising; the readership skews heavily toward senior and mid-senior pharmaceutical industry professionals — managing directors, vice presidents, general managers, heads of regulatory affairs, production directors, and marketing managers — rather than junior executives or students. This seniority profile is difficult to replicate through digital targeting alone, and it is the primary reason that high-value B2B advertisers — contract research organisations, API manufacturers, pharma equipment companies, packaging suppliers, and regulatory consultancies — consistently renew their advertising commitments in the publication year after year.

How Do You Book an Ad in Express Pharma Magazine Online?

The most direct route to book an Express Pharma ad is through the Indian Express Group's own advertising sales team, which handles print and digital ad space for all publications in the group including Express Pharma. For clients who prefer a managed process with rate negotiation support, booking through an authorised media agency — which is where SmartAds comes in — typically delivers better outcomes both in terms of pricing and in terms of ensuring that the creative specifications are met correctly the first time. We have seen self-booked campaigns run into last-minute artwork rejection issues that could easily have been avoided with proper pre-submission guidance.

For online ad booking, platforms like The Media Ant also list Express Pharma inventory and allow direct booking through their interface, which is convenient for smaller brands or one-off insertions where a full agency engagement may not be warranted. The process is relatively straightforward: you select the issue, choose the format and position, submit the artwork according to the specified creative guidelines, and make payment — after which a booking confirmation is issued. What the online platforms don't always make transparent is the availability of premium positions like the back cover ad or the inside front cover, which are often booked months in advance by regular advertisers; this is where having an agency relationship that includes advance knowledge of ad space availability becomes genuinely valuable.

The minimum lead time for booking an ad in Express Pharma is typically around two to three weeks before the issue date for standard run-of-publication positions, though premium positions often require four to six weeks' advance booking to secure. Artwork submission deadlines are usually set at ten to fourteen days before the issue date, and it is worth taking these seriously — late artwork submissions can result in your ad being bumped to a subsequent issue, which can disrupt a carefully timed product launch advertising campaign. At SmartAds, we maintain a forward booking calendar for all major trade publications including Express Pharma, which means we can advise clients on upcoming availability and help them secure premium positions before they are gone.

Which Ad Placement Positions Deliver the Best Return in Express Pharma?

The back cover ad is, without question, the highest-impact single position in Express Pharma — every person who handles the magazine sees it, whether or not they read the issue cover to cover, which gives it a frequency advantage that no inside position can match. The inside front cover is the second most valuable premium ad placement, because it is the first advertising message a reader encounters when they open the magazine; for brand awareness and product launch advertising objectives, these two positions consistently outperform run-of-publication placements on recall metrics, and the premium they command — typically 40% to 60% above the base full-page rate — is, in our view, justified for brands where first impression matters.

Within the body of the magazine, right-hand page positions are significantly more valuable than left-hand page positions, a principle that holds across all print media advertising in India and internationally; readers' eyes naturally fall on the right-hand page first when they open a spread, which means a right-hand full page ad gets a fraction more dwell time than its left-hand equivalent. The positions adjacent to high-readership editorial sections — the cover story, the regulatory affairs column, the market research pharma analysis — also tend to perform better on recall, because readers are in an engaged, information-absorbing mode when they encounter those pages. When we are advising clients on ad placement within Express Pharma, we always try to align the ad's subject matter with the adjacent editorial content where possible; an equipment manufacturer's ad placed next to the Pharma Technology Review editorial, for instance, is encountered by a reader who is already thinking about manufacturing technology.

A retail pharma client we worked with — a mid-sized contract manufacturing organisation based in Hyderabad — ran a six-month campaign in Express Pharma that specifically prioritised right-hand page placements adjacent to the regulatory affairs section, on the logic that their target audience was regulatory and quality heads who would be reading that section closely. The campaign generated a measurable increase in inbound enquiries from the target profile, and the client attributed a significant portion of three new contract manufacturing relationships — worth collectively somewhere in the range of ₹2 crore in annual revenue — to the brand visibility created by that campaign. The ROI calculation in that case was not difficult to make.

Print vs Digital Advertising in Express Pharma: Which Works Better?

Express Pharma has developed a meaningful digital presence over the years, with the expresspharma.com website carrying display advertising, sponsored content, and e-newsletter placements that complement the print edition. The digital advertising options include website banner ads in standard IAB formats, sponsored articles on the website, and e-newsletter sponsorships that reach the publication's subscriber base directly in their inboxes — which is a format we have found to be particularly effective for time-sensitive announcements like product approvals, conference invitations, and regulatory updates. The Express Pharma digital edition, which is available on platforms including Magzter, also carries advertising from the print edition and extends the reach to readers who prefer digital consumption.

The honest answer to the print versus digital question, though, is that they serve different objectives rather than competing directly. Print advertising in Express Pharma builds brand credibility and recall among the senior pharmaceutical industry professionals who still read the physical magazine as a matter of professional habit — and in our experience, this group skews toward the more senior, more influential end of the readership, which is precisely the audience that B2B pharma advertisers most want to reach. Digital advertising on the Express Pharma platform, on the other hand, is better suited to driving immediate action — website visits, event registrations, content downloads — because the clickable format enables a direct response that print cannot. A well-designed integrated campaign that uses print for brand building and digital for conversion tends to outperform either channel used in isolation, which is a principle that the FICCI-EY Media Report has consistently highlighted in its analysis of integrated media campaigns.

To be fair, there is a cost efficiency argument for digital-only campaigns among brands with limited budgets; a sponsored e-newsletter or a website banner campaign on expresspharma.com can be executed at a fraction of the cost of a full-page print insertion, and the targeting can be refined based on reader behaviour in ways that print cannot accommodate. What we tell clients who are weighing this trade-off is that the question isn't really print or digital — it's about which combination of formats best serves your specific campaign objective within your available budget. For a brand that is relatively unknown in the pharma trade and needs to establish credibility quickly, a print insertion in Express Pharma carries a legitimacy signal that a digital banner simply cannot replicate.

How Does Express Pharma Compare to Other Pharma Magazines in India?

The pharma biotech magazine landscape in India is more crowded than many brand managers realise; Express Pharma competes for advertising budgets with Chronicle Pharmabiz, Indian Pharmacist Magazine, Pharma Bio World, The Pharma Review, and Pharma Focus Asia, among others — each of which has a distinct editorial positioning and audience profile that affects its value for different types of advertisers. Chronicle Pharmabiz, published by Saffron Media, is perhaps the closest direct competitor to Express Pharma in terms of editorial scope and audience; it has a strong following among pharma trade and distribution professionals, which makes it particularly relevant for companies focused on the commercial and distribution side of the pharma business rather than the manufacturing and regulatory side.

Indian Pharmacist Magazine, as the name suggests, has a readership that skews more toward practising pharmacists and pharmacy professionals rather than pharmaceutical industry executives — which makes it a better vehicle for OTC product advertising and pharmacy retail communications than for B2B pharma advertising aimed at manufacturing or regulatory decision-makers. Pharma Bio World covers the pharmaceutical and biotechnology sectors with a somewhat more scientific and research-oriented editorial angle, which makes it valuable for biotech publication advertising aimed at R&D professionals. The Pharma Review occupies a similar space. What we tell clients who ask us to compare these publications is that the right answer depends entirely on who you are trying to reach; Express Pharma's strength is its breadth of coverage and its reach into senior management across the full spectrum of the pharma industry, which makes it the default choice for corporate branding and national campaign objectives.

On a pure circulation and readership basis, Express Pharma remains the largest and most widely distributed pharmaceutical magazine advertising platform in India, which gives it a reach advantage that matters for brand awareness campaigns. The Express Pharma ad rates are also, on a CPM basis, competitive with or better than most of its competitors when you account for the quality and seniority of the readership — a metric that TAM AdEx data on pharma category advertising spend consistently reflects in the relative share of advertising investment that flows to Express Pharma versus competing publications. One biotech company we worked with ran parallel insertions in Express Pharma and two competing pharma biotech magazines over a six-month period, tracking inbound enquiry quality from each; the Express Pharma insertions generated a higher proportion of senior-level enquiries, which ultimately translated into a better conversion rate to actual business conversations.

What Are the Special Editions and Advertorial Opportunities in Express Pharma?

The quarterly specials published under the Express Pharma umbrella represent some of the most targeted advertising opportunities in the entire pharmaceutical magazine advertising India landscape, and they are consistently underutilised by brands that focus only on the fortnightly main edition. Pharma Technology Review, which covers manufacturing technology, process innovation, and equipment, is an essential vehicle for companies selling to production and engineering heads in pharma manufacturing facilities; the readership for this special is almost entirely composed of the technical decision-makers who evaluate and approve capital equipment purchases, which makes it extraordinarily valuable for equipment manufacturers and technology vendors. LABNEXT focuses on laboratory equipment, diagnostics, and analytical instrumentation — a niche but high-value audience that is difficult to reach efficiently through any other print vehicle in India.

The Packaging Special is another quarterly that deserves more attention than it typically receives from packaging companies and material suppliers; pharmaceutical packaging is a highly regulated and technically complex area, and the professionals who make packaging decisions in pharma companies are actively looking for information about new materials, new compliance requirements, and new supplier capabilities — which means an ad in the Packaging Special is encountered by readers who are already in a purchasing-evaluation mindset. Advertorial opportunities in these special editions are particularly valuable because the longer-form format allows for the kind of technical depth that a standard display ad cannot accommodate; a well-written advertorial in the Pharma Technology Review, for instance, can effectively function as a product white paper that reaches the right audience in the right context.

At SmartAds, we have found that clients who combine a main edition full page advertisement with an advertorial in a relevant quarterly special consistently report better campaign outcomes than those who invest the same budget in multiple main edition insertions alone. The logic is straightforward: the display ad builds brand visibility and recall across the broad readership, while the advertorial in the special edition establishes technical credibility with the specific sub-audience that is closest to making a purchase decision. This combination — high-impact advertising for awareness, deep-content advertorial for consideration — is one of the most effective structures we have developed for pharmaceutical magazine advertising campaigns in India.

Creative Guidelines and Artwork Specifications for Express Pharma Ads

Getting the artwork right is one of those areas where a surprising number of campaigns run into avoidable problems, and we have seen last-minute artwork rejections disrupt otherwise well-planned product launch advertising campaigns more times than we would like to admit. Express Pharma, like all publications in the Indian Express Group, requires print-ready PDF artwork submitted at a minimum resolution of 300 DPI, with all fonts embedded and all images converted to CMYK colour mode — RGB files are not accepted for print, which catches out a lot of design teams that primarily work in digital formats. Bleed and trim specifications follow standard Indian print industry conventions, with a 3mm bleed on all sides and a safe zone of at least 5mm from the trim edge for all critical text and logo elements.

The ad creative design for a pharma trade publication like Express Pharma needs to be calibrated for a professional audience that reads critically rather than casually; this is not the place for purely emotional brand advertising that works well in consumer media. The most effective Express Pharma ads we have seen combine a clear, specific value proposition — a new product capability, a regulatory achievement, a manufacturing milestone — with strong brand identity elements and a clear call to action. Colour advertisement in Express Pharma is standard for most formats, and full-colour production is strongly recommended over black-and-white for any brand-building objective; the colour advertisement premium, where it exists, is modest relative to the impact differential.

For digital edition ads, the specifications differ from print in important ways — files need to be optimised for screen display rather than print reproduction, and interactive elements like hyperlinks can be embedded in digital edition ads in ways that are not possible in the physical magazine. The e-newsletter advertising formats follow standard HTML email specifications, with image dimensions and file size limits that need to be confirmed with the Express Pharma digital team at the time of booking. What we always recommend to clients is that ad creative design for Express Pharma campaigns be handled by a team that understands both the technical specifications and the editorial context of the publication — because an ad that looks visually out of place in a serious trade journal, regardless of how well it might work in a consumer magazine, will underperform on brand recall simply because it signals a mismatch between the advertiser and the medium.

Can Small Pharma and Biotech Brands Afford to Advertise in Express Pharma?

This is a question we get asked more often than you might expect, and the honest answer is: more often than not, yes — with some caveats about strategy. The perception that Express Pharma magazine advertising is exclusively for large multinational pharma companies is, in our experience, not supported by the actual advertiser base; a significant proportion of the advertising in any given issue comes from mid-sized Indian pharma companies, contract manufacturers, API suppliers, equipment vendors, and specialist service providers — many of which are operating on marketing budgets that are modest by MNC standards. The key for smaller brands is to be strategic about format selection and timing rather than trying to match the frequency or format scale of larger advertisers.

A half page advertisement in a single well-chosen issue — ideally one of the quarterly specials that is most relevant to the brand's target audience — can deliver meaningful brand visibility among pharma decision makers at a cost that is genuinely accessible for a mid-sized pharma or biotech company. The Express Pharma advertising cost for a half-page insertion works out to somewhere in the range of ₹45,000 to ₹65,000 plus GST, which, when measured against the quality and seniority of the audience reached, represents a reasonable investment for a brand that is trying to establish credibility in the pharma trade. Multiple insertions discount structures are available for brands that commit to three or more insertions, which can bring the effective per-insertion cost down by somewhere in the range of 10% to 20% depending on the volume and the negotiation — and this is an area where having an agency negotiate on your behalf tends to produce better outcomes than direct booking.

One small pharma startup we worked with — a contract research organisation that had been operating for about three years and was trying to break into the mid-tier pharma company client base — ran a three-insertion campaign in Express Pharma over six months, combining a half-page ad in the main edition with an advertorial in the LABNEXT special. The total campaign investment was in the range of ₹2.5 lakh including agency fees and creative production, and the client reported generating four qualified new business conversations directly attributable to the campaign — two of which converted to actual contracts within the following year. The return on investment in that case was not just positive; it was transformative for a company at that stage of its growth.

Maximising ROI from Your Express Pharma Advertising Campaign

Measuring the return on investment from print media advertising in India is admittedly less straightforward than measuring digital campaign performance, but it is far from impossible — and the brands that go in without a measurement framework tend to undervalue the results they actually achieve. The most practical approach we recommend is to create campaign-specific response mechanisms: a dedicated landing page URL printed in the ad, a specific phone extension or email address mentioned only in the Express Pharma insertion, or a QR code that links to a campaign-specific page. These mechanisms allow you to track inbound enquiries that are directly attributable to the magazine ad, which gives you a concrete data set to work with when evaluating the campaign's return on investment.

Beyond direct response tracking, brand recall surveys conducted among a sample of the target audience before and after a campaign can quantify the brand visibility impact of the insertions — a methodology that is standard in consumer advertising research and works equally well for B2B pharma advertising. The challenge is that these surveys require some investment and planning, which smaller brands often skip; but even a simple LinkedIn survey or a structured question added to the next sales call with a prospect can generate useful qualitative data about whether the Express Pharma campaign is registering with the target audience. At SmartAds, we have found that clients who invest in even a basic measurement framework consistently make better decisions about campaign renewal and format optimisation than those who rely on gut feel alone.

The strategic factors that most reliably improve ROI from Express Pharma magazine advertising are, in our experience, three: first, aligning the insertion with a news hook — a product launch, a regulatory approval, an industry event — so that the ad feels timely and relevant rather than generic; second, ensuring that the ad creative design is genuinely specific to the pharma trade audience rather than repurposed from a consumer campaign; and third, maintaining a consistent presence over at least three to six months rather than running a single insertion and expecting transformative results. Brand recall in trade media, as in all media, is built through repetition; a single insertion creates awareness, but sustained presence creates the kind of credibility that actually influences purchase decisions among pharmaceutical industry professionals.

Frequently Asked Questions About Express Pharma Magazine Advertising

Q: What is Express Pharma magazine and who is its publisher?

Express Pharma is India's leading pharmaceutical trade magazine, published fortnightly by Indian Express Limited, which is part of the Indian Express Group — one of India's most respected media conglomerates. Originally launched as Express Pharma Pulse, the publication covers the full range of topics relevant to the pharmaceutical and biotechnology industry in India, including drug development, regulatory affairs, manufacturing, packaging, market research pharma trends, and business strategy. It is headquartered in Mumbai and has been published continuously for over two decades, making it one of the most established and trusted voices in the Indian pharma media landscape.

Q: How much does it cost to advertise in Express Pharma magazine in India?

The Express Pharma advertising cost varies by format and position; a full page colour advertisement in a run-of-publication position works out to somewhere in the range of ₹80,000 to ₹1,10,000 per insertion, while the inside front cover is priced in the ballpark of ₹1,40,000 to ₹1,60,000 and the back cover ad typically runs between ₹1,60,000 and ₹1,90,000. A half page advertisement is priced somewhere between ₹45,000 and ₹65,000, and a double spread ad ranges from roughly ₹1,60,000 to ₹2,20,000 depending on position. All rates are subject to GST on magazine ads at the applicable rate, and multiple insertions discount structures are available for campaigns booked across three or more issues.

Q: What ad formats are available in Express Pharma magazine?

Express Pharma accommodates a range of print advertising formats including full page advertisements, half page advertisements, quarter page advertisements, double spread ads, the back cover ad, the inside front cover, and inside back cover positions. Advertorial formats — branded editorial content written in the publication's style — are also available and are particularly effective for complex product or technology launches. The quarterly specials (Pharma Technology Review, LABNEXT, and the Packaging Special) carry their own format menus and are booked separately from the main fortnightly edition.

Q: How do I book an advertisement in Express Pharma magazine online?

You can book an Express Pharma ad directly through the Indian Express Group's advertising sales team, through authorised online platforms like The Media Ant, or through a media agency like SmartAds that manages the booking, negotiation, and artwork submission process on your behalf. Online ad booking through platform interfaces is convenient for standard formats, but for premium positions like the back cover ad or inside front cover, direct agency engagement tends to produce better results because ad space availability for these positions is limited and often committed well in advance by regular advertisers.

Q: Who reads Express Pharma magazine — what is the target audience?

The Express Pharma readership is composed primarily of senior and mid-senior pharmaceutical industry professionals — managing directors, heads of regulatory affairs, production directors, marketing managers, procurement heads, and business development executives across pharma manufacturing companies, contract research organisations, API suppliers, and pharmaceutical service providers. The audience skews heavily toward decision-makers rather than junior staff, which is what makes it particularly valuable for B2B pharma advertising aimed at influencing procurement, partnership, and strategic decisions.

Q: What is the circulation and readership of Express Pharma magazine?

The ABC-certified circulation of Express Pharma is in the range of 25,000 to 30,000 copies per issue, with an estimated readership of 55,000 to 75,000 pharmaceutical industry professionals when pass-along readership is accounted for. The readership is concentrated in the major pharma hubs — Mumbai, Delhi, Hyderabad, Ahmedabad, and Bengaluru — with meaningful pan-India reach extending to Tier 2 and Tier 3 cities where regional pharma companies and distributors operate.

Q: Is Express Pharma magazine available in a digital edition for advertising?

Yes — Express Pharma publishes a digital edition that is available through platforms including Magzter, and the expresspharma.com website carries display advertising, sponsored content, and e-newsletter sponsorships as separate digital advertising products. The digital edition carries the same advertising as the print edition, extending reach to readers who prefer digital consumption; website banner ads and e-newsletter sponsorships are available as standalone digital placements for brands that want to reach the Express Pharma audience through digital channels specifically.

Q: How does Express Pharma compare to other pharma magazines in India for advertising?

Express Pharma is the largest and most widely distributed pharmaceutical magazine advertising platform in India by circulation and readership, which gives it a reach advantage over competitors like Chronicle Pharmabiz, Indian Pharmacist Magazine, Pharma Bio World, and The Pharma Review. Each publication has a distinct editorial focus and audience profile; Express Pharma's strength is its breadth of coverage and its penetration into senior management across the full pharma industry spectrum, which makes it the preferred vehicle for corporate branding and national campaign objectives. Chronicle Pharmabiz has a stronger following among trade and distribution professionals, while Indian Pharmacist Magazine reaches practising pharmacists more effectively.

Q: What is the lead time for booking an ad in Express Pharma magazine?

The minimum lead time for a standard run-of-publication position is typically two to three weeks before the issue date, with artwork submission deadlines set at ten to fourteen days before publication. Premium positions like the back cover ad and inside front cover often require four to six weeks' advance booking because they are in high demand and are frequently committed by regular advertisers well in advance. We always recommend building in additional buffer time for campaigns tied to specific product launches or industry events, where missing the target issue date would be particularly costly.

**Q: Are there discounts available for multiple insertions in Express Pharma